S/N | Date | Type | Topic | Speaker | Institution | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 08:30-08:45 | Speech |
Opening Ceremony |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 08:45-09:05 | Plenary lecture |
Pigmentary Disorders Update |
|
|||
2 | 09:05-09:10 | Discussion |
|
||||
3 | 09:10-09:30 | Plenary lecture |
Nutrient signaling pathways that control skin barrier function and homeostasis |
|
|||
4 | 09:30-09:35 | Discussion |
|
||||
5 | 09:35-09:55 | Plenary lecture |
Evaluation of vascular lesions in systemic sclerosis |
|
|||
6 | 09:55-10:00 | Discussion |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 10:15-10:35 | Plenary lecture |
Understanding The Asian Endotype and Phenotype in Atopic Dermatitis |
|
|||
2 | 10:35-10:40 | Discussion |
|
||||
3 | 10:40-11:00 | Plenary lecture |
Autoimmune bullous diseases in China |
|
|||
4 | 11:00-11:05 | Discussion |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 11:05-11:25 | Plenary lecture |
What's new in nail biology and pathology |
|
|||
2 | 11:25-11:30 | Discussion |
|
||||
3 | 11:30-11:50 | Plenary lecture |
The skin microbiome in acne, a shift in the paradigm of treatment |
|
|||
4 | 11:50-11:55 | Discussion |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 12:30-13:00 | Lunch Symposium |
Analysis via Novel Approach of Spatial Biology: Galactomyces Ferment Filtrate (PITERA) Strengthen the Skin Interconnectivity |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 13:00-13:15 | Lunch Symposium |
Latest research on hair synergestic damage and Pro-vitamin B5 repair mechanism |
|
|||
2 | 13:15-13:30 | Lunch Symposium |
New insight on wrinkle research based on CDL study |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 13:30-13:45 | Lunch Symposium |
Clinical features of infantile AD and scientific application of moisturisers in management |
|
|||
2 | 13:45-14:00 | Lunch Symposium |
New Data release: Experiment on the repairing and soothing efficacy and safety of Cetaphil Soothing&comforting Cream for sensitive skin |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 14:00-14:15 | Symposium |
The Role of the Skin Microbiome and Malassezia in Atopic Dermatitis: Is Malassezia Harmful or Beneficial? |
|
|||
2 | 14:15-14:30 | Symposium |
A new strategy for anti-inflammation therapy of atopic dermatitis |
|
|||
3 | 14:30-14:45 | Symposium |
Clinical and molecular heterogeneity of atopic dermatitis |
|
|||
4 | 14:45-15:00 | Symposium |
Roles of antimicrobial peptides in improvement of skin barrier and activation of autophagy in atopic dermatitis |
|
|||
5 | 15:00-15:15 | Symposium |
Benvitimod for atopic dermatitis: from bed to bench |
|
|||
6 | 15:15-15:30 | Discussion |
Q & A |
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 16:00-16:15 | Symposium |
Gut microbiome in psoriasis |
|
|||
2 | 16:15-16:35 | Other |
Enterprise Assistance Symposium |
||||
3 | 16:15-16:35 | Symposium |
WHY GPP has been foocused on so much |
|
|||
4 | 16:35-16:50 | Symposium |
Epidermal immunoenvironment play a central role in psoriasis |
|
|||
5 | 16:50-17:05 | Symposium |
Endothelial dysfunction in psoriasis |
|
|||
6 | 17:05-17:20 | Symposium |
Early Treatment of Psoriasis: A Window of Opportunity |
|
|||
7 | 17:20-17:30 | Discussion |
Q & A |
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 12:30-12:45 | Lunch Symposium |
Pigmentation Characteristics of Chinese People and Treatment Strategies |
|
|||
2 | 12:45-13:00 | Lunch Symposium |
Advanced Achievement of Skin Whitening Specifically Suitable for Chinese Skin Type |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 13:00-13:05 | Speech |
Chairman speech |
|
|||
2 | 13:05-13:30 | Lunch Symposium |
Skin care promotes cutaneous microbiome protection in an acute stratum corneum stress model in healthy volunteers and patients with inflammatory bowel diseases |
|
|||
3 | 13:30-13:58 | Discussion |
Panel Discussion / Q&A |
||||
4 | 13:58-14:00 | Summary |
Closing remarks |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 14:00-14:20 | Symposium |
Dietary supplementation in the treatment of acne |
|
|||
2 | 14:20-14:40 | Symposium |
Microecological changes and precise intervention in acne classificatio |
|
|||
3 | 14:40-15:00 | Symposium |
Introduction of the INTERNATIONAL EXPERT CONSENSUS RECOMMENDATIONS FOR USE OF DERMOCOSMETICS IN ACNE |
|
|||
4 | 15:00-15:20 | Symposium |
NAC-GED a new approach for acne treatment |
|
|||
5 | 15:20-15:30 | Discussion |
Q & A |
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 16:00-16:15 | Symposium |
585nm-590nm Light-emitting Diodes (LEDs) in Melasma Treatment:From Bench to Clinic |
|
|||
2 | 16:15-16:30 | Symposium |
Targeting the dermis for melasma treatment |
|
|||
3 | 16:30-16:45 | Symposium |
Novel Pathway Discovered in Melasma; Changing paradigms in management of Melasma |
|
|||
4 | 16:45-17:00 | Symposium |
Treatment strategy of melasma |
|
|||
5 | 17:00-17:15 | Symposium |
The mechanism of melanin transport and skin barrier changes of melasma |
|
|||
6 | 17:15-17:30 | Discussion |
Q & A |
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 12:30-12:45 | Lunch Symposium |
Clinical study on the efficacy and safety of supramolecular salicylic acid in the treatment of rosacea |
|
|||
2 | 12:45-13:00 | Lunch Symposium |
Clinical application of supramolecular salicylic acid in rosacea |
|
S/N | Date | Type | Topic | Speaker | Institution | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 13:00-13:02 | Speech |
Report on Clinical Trails of Gold Multipolar RF Beauty Instrument and Thermage |
|
|||||||||
2 | 13:02-13:10 | Lunch Symposium |
Report on Clinical Trails of Gold Multipolar RF Beauty Instrument and Thermage |
|
|||||||||
3 | 13:10-13:28 | Discussion |
Household Anti-aging Technology Discussion |
|
|||||||||
4 | 13:28-13:30 | Summary |
Closing |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 13:30-13:45 | Lunch Symposium |
The application value of TCS tapering strategy in the treatment of atopic dermatitis |
|
|||
2 | 13:45-14:00 | Lunch Symposium |
The Role of Propionibacterium Acnes and Inflammatory Responses in the Pathogenesis and Progression of Acne Vulgaris |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 14:00-14:15 | Symposium |
Cutting edges in management of auto-immune related hair and scalp disorders |
|
|||
2 | 14:15-14:30 | Symposium |
The role of Th2 in early onset and persistence of alopecia areata |
|
|||
3 | 14:30-14:45 | Symposium |
Advances in humanized animal models for alopecia |
|
|||
4 | 14:45-15:00 | Symposium |
Induced pluripotent stem cell for hair transplant |
|
|||
5 | 15:00-15:15 | Symposium |
Real-life efficacy and safety of baricitinib in Chinese patients with severe alopecia areata: a single centre prospective study |
|
|||
6 | 15:15-15:30 | Symposium |
Skin organoid self-organization and hair regeneration |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 16:00-16:20 | Symposium |
Managing refractory oral lesions in pemphigus |
|
|||
2 | 16:20-16:40 | Symposium |
Integrative single-cell analysis reveals distinct signatures of immune micro-environment and pathogenic antibody secreting cells in pemphigus cutaneous lesions |
|
|||
3 | 16:40-17:00 | Symposium |
Chronic localized blisters in pemphigus-It’s immunomechanism and therapeutic implication |
|
|||
4 | 17:00-17:20 | Symposium |
Proteses in pemphigoid diseases |
|
|||
5 | 17:20-17:30 | Discussion |
Q & A |
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 13:00-13:30 | Lunch Symposium |
Local treatment strategies for superficial fungal diseases |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 13:30-13:45 | Lunch Symposium |
Clinical Research & Innovation Strategy of Asian Sensitive Skin |
|
|||
2 | 13:45-14:00 | Lunch Symposium |
Clinical Research & Innovation Strategy of Asian Sensitive Skin |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 14:00-14:10 | Oral Presentation |
TRPV3 mediates Propionibacterium acnes-induced chemotaxis and inflammation in sebocytes |
|
|||
2 | 14:10-14:20 | Oral Presentation |
Comparison of 1064-nm Nd:YAG picosecond lasers using fractional micro-lens array vs. ablative fractional 2940-nm Er:YAG lasers for the treatment of atrophic acne scar in Asians: a 20-week prospective, randomized, split-face, controlled trial |
|
|||
3 | 14:20-14:30 | Oral Presentation |
Efficacy and Safety of Topical Minocycline Foam in Treatment of Chinese Subjects with Moderate-to-Severe Facial Acne Vulgaris: A Phase 3, Multi-center, Randomized, Double-Blind, Vehicle-controlled Study |
|
|||
4 | 14:30-14:40 | Oral Presentation |
A ‘Stress-in-a-dish' approach to evaluate skin benefits of 12-Hydroxystearic Acid |
|
|||
5 | 14:40-14:50 | Oral Presentation |
Evaluation of A Novel Microfocused Ultrasound with A Three‐Dimensional Digital Imaging for Facial Tightening: A prospective, Randomized, Controlled Trial. |
|
|||
6 | 14:50-15:00 | Oral Presentation |
A cell atlas of human skin across different anatomic sites |
|
|||
7 | 15:00-15:10 | Oral Presentation |
A study of follicular phenotypes in different regions of the occipital of male patients with androgenetic alopecia |
|
|||
8 | 15:10-15:20 | Oral Presentation |
Rose Bengal diacetate-mediated antimicrobial photodynamic inactivation: potentiation by potassium iodide and acceleration of wound healing in MRSA-infected diabetic mice |
|
|||
9 | 15:20-15:30 | Oral Presentation |
Intervention study of KPV-modified MitoQ nanoliposomes in vitiligo |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 16:00-16:10 | Oral Presentation |
The potential therapeutic benefit of a novel exopolysaccharide from Roseomonas mucosa DL-1 against skin inflammation in atopic dermatitis by Mincle-Syk axis in macrophage |
|
|||
2 | 16:10-16:20 | Oral Presentation |
TRPV3-activated parthanatos through oxidative stress contributes to atopic dermatitis |
|
|||
3 | 16:20-16:30 | Oral Presentation |
Nucleo-cytosolic acetyl-CoA drives tumor immune evasion by epigenetically regulating PD-L1 in melanoma |
|
|||
4 | 16:30-16:40 | Oral Presentation |
BET inhibitors potentiate melanoma ferroptosis through AKR1C2 inhibition |
|
|||
5 | 16:40-16:50 | Oral Presentation |
LZTR1 modulates CD8+ TRMs through NF-κB1-dependent control of MHC-I expression in epithelia |
|
|||
6 | 16:50-17:00 | Oral Presentation |
The mechanism of BET and its inhibitor NHWD-870 in regulating the lipid metabolism of psoriatic peripheral blood monocytes |
|
|||
7 | 17:00-17:10 | Oral Presentation |
Dimethyl itaconate halts vitiligo depigmentation by suppressing dendritic cell and CD8+ T cell-mediated autoimmune responses |
|
|||
8 | 17:10-17:20 | Oral Presentation |
Comparison between autologous platelet-rich plasma and 308-nm excimer light versus 308-nm excimer light alone in the management of acral vitiligo |
|
|||
9 | 17:20-17:30 | Oral Presentation |
Development of an AI-Based Image Analysis System for Accurate Assessment of Vitiligo Severity |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 14:00-14:12 | Symposium |
Omics in Psoriasis |
|
|||
2 | 14:12-14:24 | Symposium |
urticaria guidelines in resource poor settings |
|
|||
3 | 14:24-14:36 | Symposium |
A comparative study of Fractional CO2 vs Erbium 1550 in acne scar in Asian skin type |
|
|||
4 | 14:36-14:44 | Discussion |
Audience Q & A |
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 14:46-14:58 | Symposium |
Images speaks-for the diagnosis of neonatal & infantile Dermatoses |
|
|||
2 | 14:58-15:10 | Symposium |
Emerging viral exanthems -Role of dermatologist |
|
|||
3 | 15:10-15:30 | Discussion |
Audience Q & A |
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 08:00-08:05 | Speech |
Opening ceremony |
|
|||
2 | 08:05-08:10 | Speech |
Opening ceremony |
|
|||
3 | 08:10-08:15 | Speech |
Opening ceremony |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 08:15-09:15 | Other |
Enterprise Assistance Symposium |
||||
2 | 08:15-08:45 | Symposium |
Baricitinib, what every dermatologist should know |
|
|||
3 | 08:45-09:15 | Symposium |
How PsoHo study supports clinical decision making in Plaque Psoriasis |
|
|||
4 | 09:15-09:35 | Other |
Enterprise Assistance Symposium |
||||
5 | 09:15-09:35 | Symposium |
IL-36 pathway takes key role in GPP |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 09:35-09:55 | Symposium |
Research Advances in Immunotherapy of Melanoma |
|
|||
2 | 09:55-10:15 | Symposium |
Delayed inflammatory reactions after tissue filling |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 10:25-10:40 | Symposium |
The role of aminoacyl-tRNA synthetases in the pathogenesis of psoriasis |
|
|||
2 | 10:40-10:55 | Symposium |
Paroxetine is an effective treatment for refractory erythema of rosacea: primary results from the PRRERCT (Prospective Rosacea Refractory Erythema Randomized Clinical Trial) |
|
|||
3 | 10:55-11:10 | Symposium |
Exploration of SJS/TEN from Clinical Aspects to Molecular Mechanisms |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 11:10-11:25 | Symposium |
Cutaneous T Cell Lymphoma: New subtyping, new mechanism, and new advances |
|
|||
2 | 11:25-11:40 | Symposium |
The pathogenesis of drug induced adverse reactions: new progress |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 11:40-11:55 | Symposium |
New insights in the immunopathogenesis of psoriasis |
|
|||
2 | 11:55-12:10 | Symposium |
Role and application of skin microbiome in atopic dermatitis |
|
|||
3 | 12:10-12:30 | Other |
Enterprise Assistance Symposium |
||||
4 | 12:10-12:30 | Symposium |
New developments in GPP long-term management |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 12:30-12:45 | Lunch Symposium |
Exploring the Unique Value Proposition of Home Beauty Devices in Light of Evolving Regulatory Standards |
|
|||
2 | 12:45-13:00 | Lunch Symposium |
Clinical Applications of Yellow and Red LED Light Therapy in Managing Sensitive Skin Conditions |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 13:00-13:20 | Lunch Symposium |
Pioneering Integrated Skincare in China |
|
|||
2 | 13:20-13:30 | Lunch Symposium |
Healing and microbiome: From Knowledge to Dermatological Innovations ——Latest findings on the role of Microbiome in wound healing |
|
|||
3 | 13:30-13:50 | Lunch Symposium |
Healing and microbiome: From Knowledge to Dermatological Innovations ——How microbiome research can benefit Dermocosmetics |
|
|||
4 | 13:50-14:00 | Lunch Symposium |
Healing and microbiome: From Knowledge to Dermatological Innovations —— Clinical study results of a new repair product: from superficial wounds to post procedure benefits |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 14:00-14:15 | Symposium |
Non-bullous autoimmune bullous diseases |
|
|||
2 | 14:15-14:30 | Symposium |
Cutaneous deposition disorders: Tips and tricks |
|
|||
3 | 14:30-14:45 | Symposium |
Non-Langerhans cell histiocytosis |
|
|||
4 | 14:45-15:00 | Symposium |
Clinicopathological spectrum and treatment of cutaneous T-cell lymphomas |
|
|||
5 | 15:00-15:15 | Symposium |
Acral melanoma |
|
|||
6 | 15:15-15:30 |
Q & A |
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 16:00-16:15 | Symposium |
PIEZO2 transduces pruritogen-induced alloknesis. |
|
|||
2 | 16:15-16:30 | Symposium |
Peripheral mechanism of diabetic pruritus |
|
|||
3 | 16:30-16:45 | Symposium |
Latest Insights into Prurigo Nodularis Pathogenesis and Management |
|
|||
4 | 16:45-17:00 | Symposium |
Neuroimmune Circuits in Atopic Dermatitis and Relevance for treatment Options |
|
|||
5 | 17:00-17:15 | Symposium |
Hereditary angioedema: what the dermatologist needs to know? |
|
|||
6 | 17:15-17:30 | Discussion |
Q & A |
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 08:30-08:45 | Symposium |
Quality of life in vitiligo patients before and after JAK inhibitors |
|
|||
2 | 08:45-09:00 | Symposium |
Surgical Approaches to Vitiligo |
|
|||
3 | 09:00-09:15 | Symposium |
Novel understanding of vitiligo pathogenesis: focusing on CD8+T cell |
|
|||
4 | 09:15-09:30 | Symposium |
The effect of abnormal secretion of DKK1 by fibroblasts on melanocytes function in vitiligo |
|
|||
5 | 09:30-09:45 | Symposium |
Options for progressive vitiligo treatment: systemic corticosteroids or JAK inhibitors? |
|
|||
6 | 09:45-10:00 | Discussion |
Q & A |
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 10:30-10:45 | Symposium |
The use of laser for the treatment of pigmentary conditions |
|
|||
2 | 10:45-11:00 | Symposium |
Consideration in device combination therapies for skin tightening and lifting |
|
|||
3 | 11:00-11:15 | Symposium |
Update of photodynamic therapy of port wine stain |
|
|||
4 | 11:15-11:30 | Symposium |
Laser and energy based device for body contouring |
|
|||
5 | 11:30-11:45 | Symposium |
Laser for atrophic and hypertrophic scar |
|
|||
6 | 11:45-12:00 | Symposium |
What's new in laser and energy based device for dermatological application |
|
|||
7 | 12:00-12:15 | Discussion |
Q & A |
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 12:30-12:45 | Lunch Symposium |
Review of facial rejuvenation evaluation methods and experimental results of VA derivative complex combination for Asian skin |
|
|||
2 | 12:45-13:00 | Lunch Symposium |
Mechanism and evaluation of skin aging in Asian populations |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 13:00-13:30 | Lunch Symposium |
TYK2 Allosteric Inhibitor-New Breakthrough in PsO Novel Targeted Oral |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 13:30-14:00 | Lunch Symposium |
GUIDE the Future: Disease Modification in Psoriasis |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 14:00-14:20 | Symposium |
Photodynamic Therapy: A Promising Treatment for Challenging Skin Cancer |
|
|||
2 | 14:20-14:40 | Symposium |
Vascular-acting photodynamic therapy of Portwine stain - fundamentals and challenges |
|
|||
3 | 14:40-15:00 | Symposium |
Basic aspects of phototherapy and underlying mechanisms of photo(chemo)therapy |
|
|||
4 | 15:00-15:20 | Symposium |
DNA damages induced by UV irradiation and repairing by photolyase |
|
|||
5 | 15:20-15:30 | Discussion |
Q & A |
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 16:00-16:15 | Symposium |
Update on cutaneous signs of rheumatic diseases and its association to autoantibodies |
|
|||
2 | 16:15-16:30 | Symposium |
The association between systemic diseases and skin pruritus |
|
|||
3 | 16:30-16:45 | Symposium |
The skin manifestations of inflammatory bowel diseases |
|
|||
4 | 16:45-17:00 | Symposium |
Cutaneous findings in patients with immunosuppression and immunodeficiency |
|
|||
5 | 17:00-17:15 | Symposium |
Autoinflammatory diseases with mucocutaneous manifestations |
|
|||
6 | 17:15-17:30 | Symposium |
Cutaneous findings in patients with adult-onset immunodeficiency due to anti-interferon gamma autoantibodies |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 08:30-08:50 | Symposium |
Beyond the Hype: Revealing the Truth Behind Microneedle Radiofrequency Devices |
|
|||
2 | 08:50-09:10 | Symposium |
Trends in Lip Filler Techniques |
|
|||
3 | 09:10-09:30 | Symposium |
The implications of microscopic and macroscopic structures in cosmetic dermatology |
|
|||
4 | 09:30-09:50 | Symposium |
Research progress on foreign body granuloma after cosmetic injection |
|
|||
5 | 09:50-10:00 | Discussion |
Q & A |
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 10:30-10:50 | Symposium |
Acral melanoma surgery and a novel method of reconstruction |
|
|||
2 | 10:50-11:10 | Symposium |
Current Management of High Risk Cutaneous Squamous Cell Carcinoma |
|
|||
3 | 11:10-11:30 | Symposium |
What should we do before and after surgery |
|
|||
4 | 11:30-11:50 | Symposium |
The treatment strategies for Basal Cell Carcinoma |
|
|||
5 | 11:50-12:00 | Discussion |
Tumor Board and Reconstruction Conundrums |
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 12:30-12:45 | Lunch Symposium |
Pioneering Research Revealing the Importance of Stress in Relation to Skin and Hair Well-being |
|
|||
2 | 12:45-13:00 | Lunch Symposium |
Pioneering Research Revealing the Importance of Stress in Relation to Skin and Hair Well-being |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 13:00-13:30 | Lunch Symposium |
Durable control and long-term security,the first-line treatment option of moderate-to-severe atopic dermatitis |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 13:30-14:00 | Lunch Symposium |
PsO&AD: New Drug Clinical trials Progress in China |
|
S/N | Date | Type | Topic | Speaker | Institution | ||||
---|---|---|---|---|---|---|---|---|---|
1 | 14:00-14:20 | Symposium |
Physiopathological pathway of rosacea and its clinical application |
|
|||||
2 | 14:20-14:40 | Symposium |
High-sensitive sensory neurons exacerbate rosacea by activating γδ T directly |
|
|||||
3 | 14:40-15:00 | Symposium |
Patient Management and Potential Novel Treatment |
|
|||||
4 | 15:00-15:20 | Symposium |
Photodynamic therapy for Rosacea update |
|
|||||
5 | 15:20-15:30 | Discussion |
Q&A |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 16:00-16:20 | Symposium |
Nail dermoscopy |
|
|||
2 | 16:20-16:40 | Symposium |
Surgical treatment of nail unit tumors |
|
|||
3 | 16:40-17:00 | Symposium |
Six steps to standardize the surgical approach for ingrown toenail |
|
|||
4 | 17:00-17:20 | Symposium |
What's new in onychomycosis |
|
|||
5 | 17:20-17:30 | Discussion |
Q & A |
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 08:30-08:45 | Symposium |
Urticarial vasculitis |
|
|||
2 | 08:45-09:00 | Symposium |
Leukocytoclastic vasculitis presenting with various forms |
|
|||
3 | 09:00-09:15 | Symposium |
Case based approach to medium vessel and ANCA associated vasculitis |
|
|||
4 | 09:15-09:30 | Symposium |
Pyoderma gangrenosum: experience from Xiangya School of Medicine |
|
|||
5 | 09:30-09:45 | Symposium |
Cutaneous vasculitis: Clinical correlations with Pathology---Not just a window,but also a door opened for dermatologists |
|
|||
6 | 09:45-10:00 | Discussion |
Q & A |
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 10:30-10:50 | Symposium |
Diagnosing lesions at of the nipple and areola |
|
|||
2 | 10:50-11:10 | Symposium |
The Current Situation of Constution and Quality Control of Skin Imaging System in China |
|
|||
3 | 11:10-11:30 | Symposium |
Clinical and dermoscopic features of acral melanocytic tumors |
|
|||
4 | 11:30-11:50 | Symposium |
The Applications of Ultrasound Imaging in Dermatology |
|
|||
5 | 11:50-12:15 | Discussion |
Q & A |
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 12:30-13:00 | Lunch Symposium |
The research of Laser Assisted Collagen Delivery |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 13:00-13:15 | Lunch Symposium |
Clinical Application Study of Moisturizer Containing Artemisia Naphta in Sensitive Skin |
|
|||
2 | 13:15-13:30 | Lunch Symposium |
A Study on the Mechanism of a Novel Cyclic Peptide Ingredient in Improving Skin Aging |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 13:30-14:00 | Lunch Symposium |
New Insights into Precision Therapy and Disease Modification of Psoriasis |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 14:00-14:06 | Oral Presentation |
Eosinophil extracellular traps drive T follicular helper cells differentiation via VIRMA-dependent MAF stabilization in bullous pemphigoid |
|
|||
2 | 14:06-14:12 | Oral Presentation |
The mechanism of RIPK1 S331 O-GlcNAc glycosylation mediated by O-GlcNAc transferase to promote keratinocyte necroptosis in the pathogenesis of severe drug eruption |
|
|||
3 | 14:12-14:18 | Oral Presentation |
EndoS-D233Q/Q303L mediated targeted modification to enhance the anti-inflammatory efficacy of human immunoglobulin and its role in a murine model of systemic lupus erythematosus |
|
|||
4 | 14:18-14:24 | Oral Presentation |
ST6GAL1 inhibits disease progression in mice model of systemic lupus erythematosus by regulating sialylation of macrophage |
|
|||
5 | 14:24-14:30 | Oral Presentation |
Study on the Bioactive Constituents and Mechanism of Anti-Depigmentation Effect of EPIMEDII FOLIUM |
|
|||
6 | 14:30-14:36 | Oral Presentation |
Repression of the Aryl-hydrocarbon Receptor Prevents Ferroptosis of Intestinal γδT cells and Alleviates Systemic Lupus Erythematosus |
|
|||
7 | 14:36-14:42 | Oral Presentation |
Loss-of-function mutations in Keratin 32 gene disrupt skin immune homeostasis in pityriasis rubra pilaris |
|
|||
8 | 14:42-14:48 | Oral Presentation |
Keloid tissues across various anatomic sites retain positional molecular characteristics |
|
|||
9 | 14:48-14:54 | Oral Presentation |
The effect of CTNNBIP1 on Benzo(a)pyrene-induced differentiation of sebocytes in acne inversa |
|
|||
10 | 14:54-15:00 | Oral Presentation |
Unlocking Immune-Stromal Crosstalk in Bullous Pemphigoid: Insights for Type 2 Inflammatory Disease Mechanisms |
|
|||
11 | 15:00-15:06 | Oral Presentation |
A fragrance blend delivering multiple functional benefits using in-vitro methods and transcriptomics |
|
|||
12 | 15:06-15:12 | Oral Presentation |
Study on the Mechanism of lncRNA HOTAIRM1 Regulating N-Glycosylation Modification in Cutaneous T-cell Lymphoma via miR-196b-5p/MGAT4A Axis |
|
|||
13 | 15:12-15:18 | Oral Presentation |
FOXO3a Inhibits Cell Growth and Fibrosis Through Regulation of β-catenin in Keloid Fibroblasts |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 16:00-16:06 | Oral Presentation |
Low-Frequency Ultrasound Inhibits Keloids in a Piezo1-regulated manner |
|
|||
2 | 16:06-16:12 | Oral Presentation |
LncRNA TUG1 promotes fibrosis via SNAI2 in Systemic Sclerosis Dermal Fibroblasts |
|
|||
3 | 16:12-16:18 | Oral Presentation |
The regulation of the circadian clock on physiological activities of human epidermal melanocytes and its photoentrainment response |
|
|||
4 | 16:18-16:24 | Oral Presentation |
Olink Proteomics Analysis Reveals Inflammation-Related Protein Biomarkers for Female Pattern Hair Loss |
|
|||
5 | 16:24-16:30 | Oral Presentation |
Dihydrotestosterone Primed ADSC-Derived Exosoms Carring miR-185 Suppressed Hair Follicle by Regulating PI3k/Akt/GSK3β in DPCs |
|
|||
6 | 16:30-16:36 | Oral Presentation |
Aberrant connective tissue sheath contraction drives premature hair follicle regression by inducing progenitor cell depletion in androgenetic alopecia |
|
|||
7 | 16:36-16:42 | Oral Presentation |
Somatic GNAQ/GNA11 variants in a cohort of Chinese pediatrics with phakomatosis pigmentovascularis |
|
|||
8 | 16:42-16:48 | Oral Presentation |
Skin-derived precursor conditioned medium alleviated photoaging via early activation of TGF-β/Smad pathway by thrombospondin1 |
|
|||
9 | 16:48-16:54 | Oral Presentation |
Photobiomodulation using light-emitting diodes at 830 nm wavelength inhibits melanogenesis through AKT/FoxO3a pathway in human epidermal melanocytes and ex vivo skin model |
|
|||
10 | 16:54-17:00 | Oral Presentation |
Localized imiquimod ointment induced generalized psoriasiform eruption: an investigation of the rule of mast cell infiltration. |
|
|||
11 | 17:00-17:06 | Oral Presentation |
Rapid and sustained improvements with a single dose of HB0034 for treatment of generalized pustular psoriasis flares in the HB0034 Ib study |
|
|||
12 | 17:06-17:12 | Oral Presentation |
Association of metabolic syndrome and hidradenitis suppurativa in Han population |
|
|||
13 | 17:12-17:18 | Oral Presentation |
Comparison of thermal effects of monopolar and bipolar radiofrequency microneedling in porcine model: A histological study |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 08:30-08:40 | Oral Presentation |
Acromegaly presented with acne vulgaris: A retrospective study with 123 cases |
|
|||
2 | 08:40-08:50 | Oral Presentation |
Parental Awareness of Moisturizing Habits of Chinese Children with Atopic Dermatitis: A Multi-Center, Cross-Sectional Study |
|
|||
3 | 08:50-09:00 | Oral Presentation |
Efficacy and Safety of Abrocitinib in Asian Patients With Moderate-to-Severe Atopic Dermatitis |
|
|||
4 | 09:00-09:10 | Oral Presentation |
Intradermal Botulinum Toxin A Injection for Scalp Sebum Secretion Regulation: a Multi-center, Randomized, Double-blinded, Placebo-controlled, Prospective Study in Chinese Subjects |
|
|||
5 | 09:10-09:20 | Oral Presentation |
An open-label, multicenter phase 2 study of HLX07 monotherapy in the treatment of advanced cutaneous squamous cell carcinoma |
|
|||
6 | 09:20-09:30 | Oral Presentation |
Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Asian Patients With Moderate to Severe Plaque Psoriasis: Body Surface Area Involvement and Psoriasis Area and Severity Index Outcomes in the Phase 3 POETYK PSO-3 Trial |
|
|||
7 | 09:30-09:40 | Oral Presentation |
Comprehensive analysis of effectiveness and cost-effectiveness of treatments for psoriasis integrating clinician- and patient-reported outcomes: a cohort study from SPEECH |
|
|||
8 | 09:40-09:50 | Oral Presentation |
Omalizumab on Chronic Spontaneous Urticaria: A Real-World Study on Effectiveness, Safety and Predictors of Treatment Outcome |
|
|||
9 | 09:50-10:00 | Oral Presentation |
The implications of CCL19/21-CCR7 axis in Hidradenitis Suppurativa |
|
S/N | Date | Type | Topic | Speaker | Institution | ||
---|---|---|---|---|---|---|---|
1 | 10:30-10:38 | Oral Presentation |
Dupilumab in combination with JAK inhibitor for refractory moderate-to-severe atopic dermatitis |
|
|||
2 | 10:38-10:46 | Oral Presentation |
Naloxone protects against TWEAK-induced apoptolysis in pemphigus |
|
|||
3 | 10:46-10:54 | Oral Presentation |
Liposomes loaded with 5-fluorouracil can improve the efficacy in pathological scars |
|
|||
4 | 10:54-11:02 | Oral Presentation |
Case series: Clinical and pathological association of a group of cutaneous aggressive lymphomas |
|
|||
5 | 11:02-11:10 | Oral Presentation |
Treatment of severe alopecia areata in children with baricitinib: A retrospective review of 31 patients |
|
|||
6 | 11:10-11:18 | Oral Presentation |
PDT combined with localized sclerotherapy successfully treated perineal hemangioma |
|
|||
7 | 11:18-11:26 | Oral Presentation |
Treatment With Selumetinib for Café-au-Lait Macules and Plexiform Neurofibroma in Pediatric Patients With Neurofibromatosis Type 1 |
|
|||
8 | 11:26-11:34 | Oral Presentation |
Analysis of clinical characteristics of juvenile localized scleroderma |
|
|||
9 | 11:34-11:42 | Oral Presentation |
Case Series: Efficacy and safety of Spesolimab in pediatric GPP |
|
|||
10 | 11:42-11:50 | Oral Presentation |
High-Frequency Ultrasound Combined with Mohs Micrographic Surgery for the Treatment of Dermatofibrosarcoma Protuberans: Case Report and Systematic Review |
|
|||
11 | 11:50-11:58 | Oral Presentation |
Itraconazole as a novel therapy for recalcitrant pyoderma gangrenosum |
|
|||
12 | 11:58-12:06 | Oral Presentation |
Trem2 acts as a non-classical receptor of IL-4 to promote diabetic wound healing |
|